Nicholas Investment Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,103
| Closed | -$944K | – | 234 |
|
|
2024
Q3 | $944K | Buy |
+33,103
| New | +$944K | 0.09% | 186 |
|
|
2024
Q2 | – | Sell |
-137,682
| Closed | -$4.45M | – | 217 |
|
|
2024
Q1 | $4.45M | Buy |
137,682
+1,372
| +1% | +$44.3K | 0.46% | 84 |
|
|
2023
Q4 | $5.74M | Sell |
136,310
-241,845
| -64% | -$10.2M | 0.67% | 55 |
|
|
2023
Q3 | $14.5M | Buy |
+378,155
| New | +$14.5M | 1.08% | 32 |
|